Is Qsymia FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Qsymia is FDA approved and how it is commonly categorized.
Overview
Qsymia is a prescription medication that combines phentermine and topiramate extended-release for chronic weight management. It is used to support long-term weight loss in adults and certain adolescents with obesity.
FDA Status Details
Qsymia is classified as FDA Approved. It received FDA approval for chronic weight management when used alongside reduced-calorie diet and increased physical activity.
Approved Use
Qsymia is approved for adults with obesity (BMI 30+) or overweight adults (BMI 27+) with at least one weight-related medical condition. It is also approved for certain pediatric patients aged 12 and older with obesity.
Prescription Status
Qsymia is an FDA-approved branded prescription medication and should not be confused with compounded stimulant-based weight-loss products or investigational peptide therapies marketed online.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.